Abstract
Rationale Intensive care unit (ICU) acquired diaphragm weakness is a common consequence of mechanical ventilation (MV). It contributes to difficult weaning, which is associated with increased morbidity and mortality. Diaphragm weakness is caused by a combination of atrophy and dysfunction of myofibers, large syncytial cells that are maintained by a population of myonuclei. Each myonucleus provides gene transcripts to a finite fiber volume, termed the myonuclear domain. Myonuclear loss in myofibers undergoing atrophy is subject to debate. Myonuclear number is a determinant of transcriptional capacity, and therefore critical for muscle regeneration after atrophy.
Objectives Our objective was to investigate if and how myonuclear number is altered in the diaphragm of mechanically ventilated ICU patients.
Methods We used a combination of confocal microscopy, transcriptomics, and immunohistochemistry techniques to study myonuclear alterations in diaphragm and quadriceps biopsies from MV ICU patients.
Measurements and Main Results Patients with established diaphragm atrophy had a reduced myonuclear number and myonuclear domain. Intrinsic apoptotic pathway activation was identified as a potential mechanism underlying myonuclear removal in the diaphragm of mechanically ventilated ICU patients. Total transcription of myofibers decreased with myonuclear loss. Furthermore, muscle stem cell number was reduced in the patients with diaphragm atrophy.
Conclusion We identified myonuclear loss due to intrinsic apoptotic pathway activation as a mechanism underlying diaphragm atrophy in mechanically ventilated patients. The loss of myonuclei may contribute to difficult weaning due to impaired regrowth of myofibers after atrophy.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Supported by NHLBI grant HL-121500 (C.A.C.O.); ZonMW Grant 09120011910004 (C.A.C.O; L.H.)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The biopsy protocol was approved by the institutional review board at Amsterdam UMC (location VUmc), the Netherlands.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding: Supported by NHLBI grant HL-121500 (C.A.C.O.); ZonMW Grant 09120011910004 (C.A.C.O; L.H.)
Descriptor number: 4.8 (Mechanical Ventilation: Physiology & Pathophysiology)
Data Availability
All data produced in the present study are available upon reasonable request to the authors
